ILA 1 - HF & HTN Flashcards
secondary causes of HTN
glomerulonephritis, polycystic kidneys, Cushing’s, phaeochromocytoma, pregnancy, steroids, OCP
Stage 1 HTN
clinic BP greater than 140/90 and ABPM average greater than 135/85
Stage 2 HTN
clinic BP greater than 160/100 and ABPM average greater than 150/95
Severe HTN
clinic BP greater than 180 over 110
Accelerated HTN
severe HTN with visible end organ damage
Who to treat for HTN
Any stage 2. Stage 1 if under 80 and have end organ damage, CVD, renal disease, DM, QRisk2 score over 20%
QRisk2 score
10 year risk of having a CV event. Incoperates age, sex, smoking, DM, AF, CKD, blood pressure, cholesterol/HDL ratio.
Microvascular effects of HTN
retinopathy, nephropathy, neuropathy.
Microvascular effects of HTN
Atherosclerosis, stroke, MI, peripheral vascular disease
HTN treatment 1st pharmacological step
If under 55 ACE inhibitor e.g. ramipril or angiotensin 2 receptor blocker e.g. losartan. If over 55 or afro-carribean give CCB e.g. nifedipine.
Patient group where ACEi won’t work
Those with renal artery stenosis will see BP increase on ACEi
HTN 2nd line pharmacological treatment
ACEi + CCB or if afro-cab ARB + CCB
HTN 3rd line pharmacological treatment
add thiazide-like diuretic e.g. indapamide
4th line HTN pharmacology treatment
potassium sparing diuretic (if baseline K+ levels good), alpha or beta blocker. If poor K+ levels increase thiazide like diuretic dose.
Investigations in HTN patient and findings
ECG: left ventricular hypertrophy causing big T waves or post MI. Urinalysis: protein. Echovardiogram: LV hypertrophy. Bloods: U&E, creatinine, fasting glucose, cholesterol.